Nebula is free while in beta — browse the evidence map with no account.Open Nebula →
AEaH.aiEvidence · Intelligence

trial · primary record

Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan

Immune Deficiency Disorders

PhasePhase 2
StatusCOMPLETED
SponsorUnknown
Enrolment28
Primary completion2026-04-23
Primary endpointNumber of Participants With Donor Engraftment
Registry IDNCT01821781

Provenance

  • Source: ClinicalTrials.gov
  • Fetched at: 2026-10-28T02:33:14.224Z
  • Licence class: attribution-required
  • Verdict: primary-source
  • Entity id: NCT01821781

This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.

Start monitoring — $199/monthAll trial records
Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan — trial | AEaH